Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CombineMed is an Israeli medical technology company that developed an innovative system for the automated preparation of injectable medications in hospital settings. The company's primary focus was on enhancing patient safety by reducing human errors during the complex process of compounding and preparing intravenous (IV) drugs. Its flagship technology integrates hardware and software to ensure precise dosing and labeling, streamlining pharmacy workflows and improving clinical accuracy. In October 2014, CombineMed was acquired by Becton, Dickinson and Company (BD) to bolster its medication management and safety portfolio. Following the acquisition, CombineMed's technology was integrated into BD's broader suite of clinical solutions aimed at preventing medication errors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CombineMed.